Post by
TataTrading on Mar 31, 2021 10:23am
04/13/16 - Immunovaccine Names Frederic Ors Chief Executive
At the end of that day the stock was at $1.9872 or $6.36 after the 3.2 reverse split.
Close to celebrating this 5 year anniversary, the stock is now at $3.92. 38.3% decline
All is said. This was a huge mistake. Ors, must GO ASAP.
Comment by
TexasTea20 on Apr 01, 2021 7:04pm
I do agree with your sentiment re Ors. The guy just doesnt resonate with investors. Needs to be demoted or moved into a different role. I really don't like it when CEO's are on the BOD. This entire week has once again highlighted this company's managerial short-comings.
Comment by
gardy on Apr 02, 2021 2:09pm
Ors is a spud filling up at the trough. I wish I could make over a million per annum leading a company that has not made one penny. As for management being on the board, can you say conflict of interest. Nothing but white collar shenanigans. Starting to lose faith that this company will amount to anything. Their's my rant, I feel better now. NOT! Gardy